Cargando…

Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches

BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotini...

Descripción completa

Detalles Bibliográficos
Autores principales: Claire, Ravinder, Coleman, Tim, Leonardi‐Bee, Jo, Berlin, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771792/
https://www.ncbi.nlm.nih.gov/pubmed/31106486
http://dx.doi.org/10.1111/add.14662
_version_ 1783455768237834240
author Claire, Ravinder
Coleman, Tim
Leonardi‐Bee, Jo
Berlin, Ivan
author_facet Claire, Ravinder
Coleman, Tim
Leonardi‐Bee, Jo
Berlin, Ivan
author_sort Claire, Ravinder
collection PubMed
description BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post‐target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo. DESIGN AND SETTING: Controlled pre–post design stratified by intervention condition from the ‘Study of Nicotine Patch in Pregnancy’, a randomized, placebo‐controlled trial. PARTICIPANTS: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date. MEASUREMENTS: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants’ target quit dates. Any smoking in the previous week was assessed by self‐report, validated by expired air carbon monoxide (CO). FINDINGS: There was no change in saliva cotinine concentrations between baseline and 2 weeks post‐target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference −6, 95% CIs −7 to −5, P < 0.001) and in CO concentrations (mean difference −3.0 parts per million, 95% CIs −4.2 to −1.9, P < 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046). CONCLUSIONS: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post‐target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations.
format Online
Article
Text
id pubmed-6771792
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67717922019-10-07 Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches Claire, Ravinder Coleman, Tim Leonardi‐Bee, Jo Berlin, Ivan Addiction Research Reports BACKGROUND AND AIMS: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post‐target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo. DESIGN AND SETTING: Controlled pre–post design stratified by intervention condition from the ‘Study of Nicotine Patch in Pregnancy’, a randomized, placebo‐controlled trial. PARTICIPANTS: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date. MEASUREMENTS: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants’ target quit dates. Any smoking in the previous week was assessed by self‐report, validated by expired air carbon monoxide (CO). FINDINGS: There was no change in saliva cotinine concentrations between baseline and 2 weeks post‐target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference −6, 95% CIs −7 to −5, P < 0.001) and in CO concentrations (mean difference −3.0 parts per million, 95% CIs −4.2 to −1.9, P < 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046). CONCLUSIONS: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post‐target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations. John Wiley and Sons Inc. 2019-06-30 2019-09 /pmc/articles/PMC6771792/ /pubmed/31106486 http://dx.doi.org/10.1111/add.14662 Text en © 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Reports
Claire, Ravinder
Coleman, Tim
Leonardi‐Bee, Jo
Berlin, Ivan
Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title_full Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title_fullStr Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title_full_unstemmed Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title_short Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
title_sort saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771792/
https://www.ncbi.nlm.nih.gov/pubmed/31106486
http://dx.doi.org/10.1111/add.14662
work_keys_str_mv AT claireravinder salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches
AT colemantim salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches
AT leonardibeejo salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches
AT berlinivan salivacotinineconcentrationsinpregnantwomenwhosmokeandusenicotinepatches